Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Omicron-adapted COVID-19 booster vaccines; guidance for the 2022-23 influenza season; efficacy of COVID-19 antiviral; ‘rainbow fentanly’ targeting youth; and a device to treat chronic idiopathic constipation.
Please login or register first to view this content.
